Check out which companies are making headlines before the bell:
Target – The retailer is facing an increasing number of lawsuits and a drop in sales, following the massive data breach. Retail consultancy Customer Growth Partners said Target saw customer traffic drop five percent last weekend, following news that hackers stole data from up to 50 million credit and debit cards.
Tesla –The 5-star safety rating for the Model S has been reaffirmed by the National Highway Traffic Safety Administration for Model Year 2014. Tesla is still awaiting NHTSA's conclusions on its investigation of recent fire-related incidents involving the Model S.
W.R Grace – The company is set to exit a 12-year stay in bankruptcy, after settling the only remaining appeal in its exit plan with a group of bank lenders. The chemicals maker filed for bankruptcy protection in 2001, following an asbestos leak at a company mine that resulted in numerous lawsuits.
CalAmp – The satellite technology provider posted earnings that exceeded Street expectations, but its outlook fell short of analyst forecasts.
Blackstone– The private equity firm's La Quinta hotel chain has confidentially filed for an initial public offering, under a law which allows company to keep certain details of an IPO secret. Reuters had previously reported that Blackstone was seeking as much as $4.5 billion for La Quinta.
Johnson & Johnson – Carlyle is in exclusive talks to buy J&J's blood testing unit, according to the Wall Street Journal, which said the firm has emerged from a number of bidders as the most likely to pull off a deal.
PulteGroup, D.R. Horton, Beazer, Lennar – We'll follow shares of home builders today, following news from the Mortgage Bankers Association that mortgage applications fell to a 13-year low last week. Mortgage rates rose following the Federal Reserve's move last week to taper its bond-buying program.
Baxter International – Baxter has issued a recall for certain lots of two of its intravenous solutions, due to an occurrence of particulate matter. Such matter can result in organ damage, although Baxter has not received any reports of adverse events related to the issue.
—By CNBC's Peter Schacknow
Questions? Comments? Email us at firstname.lastname@example.org